Sveriges mest populära poddar

A New Alzheimer's Drug Brings Hope and Controversy

23 min•11 juni 2021

The FDA this week approved the first new Alzheimer's treatment in nearly 20 years. But it almost didn't make it to market. WSJ's Joseph Walker untangles the complex story behind the drug Aduhelm and why its approval is raising questions.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Fler avsnitt av The Journal.

Let’s Talk Bonds. Treasury Bonds.

21 aug.•21 min

Why Flock Cameras Are Facing Backlash

20 aug.•20 min

Why Are Some StubHub Customers So Mad?

19 aug.•24 min

He's Been a Costco Cashier for 40 Years. Now He's a Millionaire.

18 aug.•17 min

This Opioid Alternative Is Fueling an Addiction Crisis

17 aug.•18 min

The Live Auction App Where People Can Bid ‘Til They’re Broke

14 aug.•27 min

He Thought He Invested in SpaceX. Then His Shares Vanished.

13 aug.•22 min

To Solve a Cold Case, French Police Bent DNA Privacy Law

12 aug.•25 min

Jared Kushner's Albania Headache: Flamingos, Contested Land and Cocaine

11 aug.•22 min

Y Combinator CEO on How AI is Changing What Startups Build

10 aug.•26 min

The Journal. med The Wall Street Journal & Spotify Studios finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.